Studies utilizing FlowSOM unveiled the intrinsic heterogeneity within populations of particular interest in SLE, like peripheral helper T-cells and CD11c+ B-cells, both reportedly expanded in SLE linked with disease severity (11–13). This evidence concerns the gene ITGAX and systemic lupus erythematosus.